Evidence mapPaperPMID 42416261Full record

ArticleTransplantation direct2026

Quality Assessment of Discarded Human Kidneys Using Normothermic Perfusion.

Enrique Montagud-Marrahi, Thomas Prudhomme, Tarek Ajami, Cristina García-Parejo, Lluis Peri, Adriana Rodriguez-Gonzalo, Yosu Luque, Antoni Vilaseca, Ruben Rabadan-Ros, Elena Cuadrado-Payan and 10 more

Abstract read
In one paragraph

Article in Transplantation direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Enrique Montagud-MarrahiKidney Transplant Unit, Nephrology and Kidney Transplantation Department, Hospital Clinic of Barcelona, Spain.ORCID https://orcid.org/0000-0002-5940-8962
Thomas PrudhommeNantes University, CHU Nantes, INSERM, Centre for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
Tarek AjamiGenetics and Urological Tumors, Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Cristina García-ParejoKidney Transplant Unit, Nephrology and Kidney Transplantation Department, Hospital Clinic of Barcelona, Spain.
Lluis PeriUrology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
Adriana Rodriguez-GonzaloNephrology and Transplant Laboratory (LENIT), Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Yosu LuqueKidney Transplant Unit, Nephrology and Kidney Transplantation Department, Hospital Clinic of Barcelona, Spain.
Antoni VilasecaUrology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
Ruben Rabadan-RosGroup of Metabolism and Genetic Regulation of Disease, UCAM HiTech Sport and Health Innovation Hub, Catholic University of Murcia, Murcia, Spain.
Elena Cuadrado-PayanKidney Transplant Unit, Nephrology and Kidney Transplantation Department, Hospital Clinic of Barcelona, Spain.
Elisenda Bañón-ManeusNephrology and Transplant Laboratory (LENIT), Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Jordi RoviraNephrology and Transplant Laboratory (LENIT), Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Maria José Ramírez-BajoNephrology and Transplant Laboratory (LENIT), Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Lourdes MengualGenetics and Urological Tumors, Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Mercedes IngelmoGenetics and Urological Tumors, Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Ana Belén LarqueDepartment of Pathology, Hospital Clinic of Barcelona, Barcelona, Spain.
Antonio AlcarazGenetics and Urological Tumors, Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.
Josep M CampistolKidney Transplant Unit, Nephrology and Kidney Transplantation Department, Hospital Clinic of Barcelona, Spain.
Fritz DiekmannKidney Transplant Unit, Nephrology and Kidney Transplantation Department, Hospital Clinic of Barcelona, Spain.
Mireia MusqueraGenetics and Urological Tumors, Foundation for Biomedical Research-August Pi i Sunyer Biomedical Research Institute (FCRB-IDIBAPS), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ex vivo normothermic perfusion (EVNP) allows for comprehensive functional assessment; however, current scoring systems are validated only for short perfusion durations. This study investigates the utility of the EVNP quality assessment score for a 6-h period to predict viability in discarded human kidneys. Methods: Twenty human kidneys from marginal donors, previously declined for transplantation, underwent 6-h EVNP. Functional parameters (renal blood flow, resistance index, urine output), perfusate biochemistry, tissue injury biomarkers, and histology were assessed. Kidneys were stratified by EVNP score: group A (1-2), group B (3), and group C (4-5). Results: Group A demonstrated significantly higher renal blood flow (median 213.5 versus 145.1 [B] versus 81.7 mL/min [C], Conclusions: The EVNP score may assist in identifying kidneys with potential for transplantation despite suboptimal histology, which could contribute to reducing the underutilization of marginal grafts.

Identifiers

PMID42416261
PMCPMC13340721

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.